🎗️ Oncology Papers

Scholarly works matching "oncology" in Crossref, sorted by the number of times other DOI-registered works cite them. Citation counts come from Crossref and are usually lower than Google Scholar figures.

575 top-cited papers indexed

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

N. K. Aaronson, S. Ahmedzai et al. (1993)

JNCI Journal of the National Cancer Institute

13.6K citesjournal articlePDF

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

David N Louis, Arie Perry et al. (2021)

Neuro-Oncology

11.5K citesjournal articlePDF

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Martin M. Oken, Richard H. Creech et al. (1982)

AMERICAN JOURNAL OF CLINICAL ONCOLOGY

9.6K citesjournal articlePDF

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

Stephen B. Edge, Carolyn C. Compton (2010)

Annals of Surgical Oncology

6.8K citesjournal articlePDF

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Roger Stupp, Monika E Hegi et al. (2009)

The Lancet Oncology

6.8K citesjournal articlePDF

Oncology Meets Immunology: The Cancer-Immunity Cycle

Daniel S. Chen, Ira Mellman (2013)

Immunity

6.3K citesjournal articlePDF

Hallmarks of aging: An expanding universe

Carlos López-Otín, Maria A. Blasco et al. (2023)

Cell

6.6K citesjournal articlePDF

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

D F Cella, D S Tulsky et al. (1993)

Journal of Clinical Oncology

5.1K citesjournal articlePDF

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Ann-Lii Cheng, Yoon-Koo Kang et al. (2009)

The Lancet Oncology

4.9K citesjournal articlePDF

Definition and classification of cancer cachexia: an international consensus

Kenneth Fearon, Florian Strasser et al. (2011)

The Lancet Oncology

5.2K citesjournal articlePDF

Radiomics: the bridge between medical imaging and personalized medicine

Philippe Lambin, Ralph T.H. Leijenaar et al. (2017)

Nature Reviews Clinical Oncology

5.2K citesjournal articlePDF

Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

Bruce D. Cheson, Richard I. Fisher et al. (2014)

Journal of Clinical Oncology

5.1K citesjournal articlePDF

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

H A Burris, M J Moore et al. (1997)

Journal of Clinical Oncology

4.7K citesjournal articlePDF

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

Rafael Rosell, Enric Carcereny et al. (2012)

The Lancet Oncology

4.4K citesjournal articlePDF

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

S Vincent Rajkumar, Meletios A Dimopoulos et al. (2014)

The Lancet Oncology

4.3K citesjournal articlePDF